💨 Abstract
Indian pharmaceutical experts anticipate collaboration with the US in healthcare security and affordability, as these are priorities for the new Trump Administration. Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, believes that India and the US can collaborate to strengthen their pharmaceutical supply chains and advance healthcare.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Two-year-old US citizen appears to have been deported 'with no meaningful process'
Iran, US to resume talks in Oman to narrow gaps over new nuclear deal
Pakistan military resorts to unprovoked firing along LoC
Employment in India grown faster than working-age population: World Bank report
China foreign minister says US tariffs show "extreme egoism"
In reversal, US Justice Department says media records can be seized in leak probes
US Treasury's Bessent urges Asian Development Bank to move towards ending China loans
US: Luigi Mangione, accused of killing UnitedHealthcare CEO, pleads not guilty to federal charges
US and EU not close to deal on tariffs - EU's Dombrovskis
Rubio replaces top US diplomat for Europe with former Senate staffer, consultant
Powered by MessengerX.io